Inventaire - your friends and communities are your best library

Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

author

Anne Zeleniuch-Jacquotte

Claudia Agnoli

Dale Sandler

2000 -

Anthony Swerdlow

Minouk J Schoemaker

2000 -

Göran Hallmans

A Heather Eliassen

Malin Sund

1972 -

Susan E. Hankinson

Tess V Clendenen

Karen L Koenig

Joanne F Dorgan

Roni T Falk

Judith Hoffman-Bolton

Vittorio Krogh

2000 -

Kala Visvanathan

published in: International Journal of Cancer

date of publication: 2018-01-08

language: English

Cites articles 56

Date

Title

Authors

2017-09-11

Re-Appraisal of Estrogen Receptor Negative/Progesterone Receptor Positive (ER-/PR+) Breast Cancer Phenotype: True Subtype or Technical Artefact?

Sean O Hynes
2016-09-09

Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group
2016-03-09

Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies

Anne Zeleniuch-Jacquotte, A Heather Eliassen, Susan E. Hankinson, Bernard A Rosner
2015-12-28

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

Charles M. Perou, Traci N Bethea, Christine Ambrosone, Andrew F. Olshan
2015-10-01

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society
2015-08-04

Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer

Gene P. Siegal
2015-08-12

Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Christine Clarke
2015-07-10

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer

Alberto Ocana, Eitan Amir, Francisco Vera-Badillo, Robyn Goldstein
2015-06-16

Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study

Yvonne T van der Schouw
2015-04-14

Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk

Donna Baird, Kristina W Whitworth, Dale Sandler
2014-09-17

Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors

Patricia K. Donahoe
2014-04

The ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link?
2014-02-11

Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study

Minouk J Schoemaker, Anthony Swerdlow, Alan Ashworth
2013-12-15

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
2013-01-01

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype

Benjamin Haibe-Kains, Marco M Hefti, Rulla M Tamimi
2013-07-24

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies

Kim Overvad, Louise A. Brinton, Elio Riboli, Rudolf Kaaks, Aurelio Barricarte, A Heather Eliassen, Paolo Vineis, Shelley S. Tworoger, Dimitris Trichopoulos, Susan E. Hankinson, Vittorio Krogh, Sabina Sieri, Renée Turzanski Fortner, Endogenous Hormones and Breast Cancer Collaborative Group
2013-03-06

Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II

Donna Spiegelman, Renée Turzanski Fortner, A Heather Eliassen, Walter C. Willett, Susan E. Hankinson, Robert L. Barbieri
2013-02-26

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study

Anne Zeleniuch-Jacquotte, Göran Hallmans, Roy E Shore, Per Lenner, Eva Lundin, Sabina Rinaldi, Alan A Arslan, Tess V Clendenen, Karen L Koenig, Stephanie Scarmo
2013-01

Impact of breast cancer on anti-mullerian hormone levels in young women
2012-10-17

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
2012-10-04

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers

Charles M. Perou, Mark Ebbert, Aleix Prat, Kenneth Boucher, Ignacio Aranda, Miguel Martin, Sébastien Roy, Blanca Munárriz, Manuel Ruiz-Borrego, E Alba, Inge J Stijleman, Eva Carrasco, Rosalía Caballero
2012-05

Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women

Ellen W Freeman
2012-02-16

Premenopausal serum androgens and breast cancer risk: a nested case-control study

Anne Zeleniuch-Jacquotte, Rudolf Kaaks, Roy E Shore, Sabina Rinaldi, Alan A Arslan, Karen L Koenig, Stephanie Scarmo
2011-10-22

A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance
2011-09-06

The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology

Anthony Swerdlow, Minouk J Schoemaker, Alan Ashworth, David M Thomas
2011

A validated model of serum anti-müllerian hormone from conception to menopause

Thomas W. Kelsey, Scott M. Nelson, Hamish Wallace
2011-05-26

Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer
2011-07-01

Predicting age at menopause from serum antimüllerian hormone concentration
2010-11-18

Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk

Louise A. Brinton, Frank Z. Stanczyk, Lisa L. Kahle
2009-10-09

Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk

Louise A. Brinton, Frank Z. Stanczyk, Lisa L. Kahle
2009-05-05

Assay reproducibility and within-person variation of Müllerian inhibiting substance

Louise A. Brinton, Lisa L. Kahle
2008-01-01

Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?

Nathalie Pochet, Wouter Hendrickx, Marie-Rose Christiaens, Ignace Vergote, Frédéric Amant, Patrick Neven, Karin Leunen

Article - wd:Q48283361

Welcome to Inventaire

the library of your friends and communities

learn more